Biodesix Return on Investment 2020-2025 | BDSX
Current and historical return on investment (ROI) values for Biodesix (BDSX) over the last 10 years.
| Biodesix ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-03-31 | $-0.03B | $0.05B | -54.77% |
| 2024-12-31 | $-0.04B | $0.06B | -62.78% |
| 2024-09-30 | $-0.04B | $0.06B | -67.96% |
| 2024-06-30 | $-0.03B | $0.07B | -79.52% |
| 2024-03-31 | $-0.04B | $0.03B | -128.57% |
| 2023-12-31 | $-0.04B | $0.04B | -146.43% |
| 2023-09-30 | $-0.05B | $0.02B | -162.71% |
| 2023-06-30 | $-0.05B | $0.02B | -216.67% |
| 2023-03-31 | $-0.05B | $0.03B | -225.53% |
| 2022-12-31 | $-0.05B | $0.05B | -248.78% |
| 2022-09-30 | $-0.05B | $0.00B | -296.97% |
| 2022-06-30 | $-0.05B | $0.02B | -185.45% |
| 2022-03-31 | $-0.05B | $0.02B | -133.33% |
| 2021-12-31 | $-0.04B | $0.03B | -84.42% |
| 2021-09-30 | $-0.03B | $0.05B | -58.41% |
| 2021-06-30 | $-0.03B | $0.06B | 189.09% |
| 2021-03-31 | $-0.02B | $0.07B | 75.68% |
| 2020-12-31 | $-0.02B | $0.06B | 51.69% |
| 2020-06-30 | $-0.02B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.055B | $0.071B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.067B | 27.09 |
| CVS Health (CVS) | United States | $78.811B | 9.80 |
| Elevance Health (ELV) | United States | $66.101B | 8.89 |
| Cencora (COR) | United States | $56.558B | 19.68 |
| DiDi Global (DIDIY) | China | $24.238B | 25.75 |
| Labcorp Holdings (LH) | United States | $22.089B | 17.43 |
| Natera (NTRA) | United States | $19.248B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.897B | 0.00 |
| ICON (ICLR) | Ireland | $14.657B | 14.10 |
| CochLear (CHEOY) | Australia | $13.278B | 0.00 |
| Solventum (SOLV) | United States | $12.626B | 13.37 |
| Medpace Holdings (MEDP) | United States | $12.299B | 32.55 |
| Revvity (RVTY) | United States | $10.708B | 18.58 |
| Viatris (VTRS) | United States | $10.563B | 3.63 |
| Avantor (AVTR) | United States | $9.404B | 13.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.886B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.654B | 16.96 |
| HealthEquity (HQY) | United States | $8.544B | 37.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.505B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.851B | 32.64 |
| Amplifon S.p.A (AMFPF) | Italy | $3.871B | 21.19 |
| BrightSpring Health Services (BTSG) | United States | $3.746B | 34.37 |
| Sotera Health (SHC) | United States | $3.382B | 19.22 |
| GeneDx Holdings (WGS) | United States | $2.953B | 68.10 |
| Surgery Partners (SGRY) | United States | $2.867B | 37.28 |
| Concentras Parent (CON) | United States | $2.615B | 15.11 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| Alignment Healthcare (ALHC) | United States | $2.572B | 0.00 |
| Progyny (PGNY) | United States | $2.014B | 44.34 |
| Premier (PINC) | United States | $1.772B | 13.45 |
| GoodRx Holdings (GDRX) | United States | $1.747B | 34.93 |
| PACS (PACS) | United States | $1.710B | 0.00 |
| Ardent Health (ARDT) | United States | $1.528B | 6.51 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.213B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.065B | 8.10 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.791B | 0.00 |
| CareDx (CDNA) | United States | $0.716B | 11.18 |
| AMN Healthcare Services Inc (AMN) | United States | $0.712B | 6.67 |
| Embecta (EMBC) | United States | $0.611B | 4.11 |
| So-Young (SY) | China | $0.501B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.479B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| Nutex Health (NUTX) | United States | $0.467B | 7.06 |
| LifeMD (LFMD) | United States | $0.459B | 0.00 |
| Omada Health (OMDA) | $0.455B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.455B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.454B | 10.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.369B | 0.00 |
| Enhabit (EHAB) | United States | $0.338B | 27.83 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.270B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.096B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| KindlyMD (NAKA) | United States | $0.058B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.013B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |